目的：探讨图像细胞术测定肾细胞癌DNA倍体和核形态参数在预后判断上的价值及其与病变分级的关系。
Objective:To determine the prognostic value of DNA ploidy and nuclear morphometry, and its relations to nuclear grading in renal cell carcinoma.
目的：初步探讨膀胱癌彩色多普勒血流显像与肿块大小及病理分级的关系。
Objective: to explore the relation of Color Doppler Flow Imaging in bladder tumors and the tumor size and pathology classification.
目的探讨40岁以下膀胱癌患者临床表现、病理分级、治疗与预后的特点。
Objective To evaluate the clinical features, pathological grades, treatment and prognosis in bladder cancer patients under 40 years.
结论：国人非遗传性肾透明细胞癌中存在VHL基因的突变，且与患者年龄，肿瘤分期、分级无相关性。
The mutations of VHL gene were irrespective of the age and pathological grade and stage of patients.
预后主要取决于输尿管癌的分期和分级。
The prognosis mainly depend on the stage and pathology grade of the carcinoma.
肿瘤的类型、临床分期、门脉癌栓、肝功能分级是影响疗效的主要因素。
The type of carcinoma, the clinical stage of the disease, the cancer embolus of portal vein, the classification of liver function are the main factors affecting treatment efficacy.
目的：了解LRIG2基因及其产物在膀胱癌中的表达情况及其与肿瘤分级分期的关系。
Objective: to investigate the expression of LRIG2 gene and it's product in bladder cancer and their relation to the staging and grading of tumors.
手术方式和治疗预后取决于胆囊癌的分期及分级。
The surgery way and the treatment prognosis are decided by the stages and the graduation of gallbladder carcinoma.
结果MMP2，MMP9在膀胱癌中呈高表达，且随分期、分级的增高而增高；
Results MMP2 and MMP9 were highly expressed in tumor samples and their expression rates increased with grades and stages.
统计分析口腔癌NOS表达水平与淋巴转移、病理分级、临床分期的关系；分析口腔癌NOS表达水平与口腔癌组织微血管密度、VEGF表达水平之间的夫系。
Relationships of NOS expression with metastasis, pathological type and TNM stages were analyzed in OSCC, and so were relationship of NOS expression with VEGF expression and MVD.
目的：调查徐州矿务集团女工宫颈癌的发病情况，评价TBS分级系统的诊断价值。
Objective: To investigate the illness of cervical carcinoma in the female workers of Xuzhou Mineral Group Company and evaluate the value in diagnosis of TBS system.
但FACL4表达水平与患者的性别，年龄，肿瘤大小，包膜的完整与否，分级，癌栓形成及血清AFP水平未见明显相关性（均P＞0.05）。
The expression of HSF1 mRNA and FACL4 mRNA were not associated with the patient's gender, age, tumor size, pathologic grade, pathologic type, as well as level of serum AFP(P>0.05).
方法采用数字疼痛分级法（NRS），对200例晚期癌症患者的癌痛程度进行评估；
Methods Evaluating pain degrees of 200 late staged cancer patients against Numerical Rating Scale (NRS).
卵巢癌是妇科恶性肿瘤中致死率最高的肿瘤，目前通常用于判断卵巢癌预后的指标有FIGO分期、肿瘤分级、肿瘤组织学类型等。
Ovarian carcinoma is the most lethal gynecologic malignancy. Nowadays, conventional prognostic markers in ovarian cancer have included FIGO stage, tumor grade, histology et al.
结论临床分期和肿瘤分级是有效的预后判断依据，早期诊断、早期治疗对改善肾盂癌患者的预后具有积极作用。
Conclusions tumor stage and grade are effective prognostic indicators. Early diagnosis and treatment of tumors are critical for improving the prognosis of carcinoma of renal pelvis.
其表达与肿瘤病理分期、细胞分级有关，可能是判断肾盂输尿管癌预后的一个重要指标。
C-erb B-2 expression correlates well with the pathologic grade and the cellular phase of the tumor and its clinical stage and might serve as a prognostic marker of ureteral and renal pelvic cancer.
方法：通过分别对于35例口腔鳞状细胞癌表面区、中心区、深层浸润区进行WHO病理分级，观察、评估不同区域的病理学分级是否存在差异。
Methods: Surface, center deep infiltration part of 35 OSCC cases were graded respectively (WHO grading1971). To observe where there were differences of pathological grading between these parts.
ODC的活性与卵巢癌组织分级呈正相关。
EGFR表达与喉鳞状细胞癌的病理组织分级及患者5年生存期相关（P< 0 .0 5 ） ；
EGFR expression in LSCC was related to the degree of cell differentiation and 5 years survival rate of patients ( P< 0.05).
MT的表达与癌组织的分级、类型和角化型鳞癌的淋巴结转移有关（P<0 0 1，P< 0 0 5 ）。
The expression of MT was related to histological grades, patterns and lymph nodes metastasis of keratinized squamous cell carcinoma( P<0 01, P<0 05 ).
癌灶的增强值的变化与MVD呈正相关，与病理分级呈负相关。
CT enhancement was positively related to MVD and negatively related to the tumor stages.
VEGF的阳性表达与食管鳞状细胞癌患者的性别、年龄、病理分级、肿瘤长度无明显相关性（P＞0.05）；
Positive rate of VEGF in esophageal squamous cell carcinoma was 78.0%, which is higher than the normal group, the difference was significant (P<0.05).
Thymopoietin蛋白在卵巢癌不同病理分级、临床分期、有无转移和病理类型之间的比较，差异均无统计学意义。
Differences of thymopoietin expression in ovarian cancer with different histological grade, clinical stage, metastasis and pathological types were not statistically significant.
Thymopoietin蛋白在卵巢癌不同病理分级、临床分期、有无转移和病理类型之间的比较，差异均无统计学意义。
Differences of thymopoietin expression in ovarian cancer with different histological grade, clinical stage, metastasis and pathological types were not statistically significant.
应用推荐